Relationship of regional adiposity to serum leptin level in nonobese Japanese type 2 diabetic male patients

Diabetes and Metabolism

Volumn 29, Issue 1, 2003, Pages 15-18

  Okumura, T ^a   Taniguchi, A ^a   Nagasaka, S ^b   Sakai, M ^a   Fukushima, M ^c   Kuroe, A ^a   Yoshii, S ^a   Nakamura, T ^b   Ogura, M ^a   Atarashi, T ^a   Nishida, S ^a   Nakai, Y ^d  

^a KANSAI DENRYOKU HOSPITAL   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

Leptin; Male; Nonobese; Regional Adiposity; Type 2 Diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; JAPAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROTEIN BLOOD LEVEL; SUBCUTANEOUS FAT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0037303068     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)70002-2     Document Type: Article

References (23)

1. Halaas JL, Gajiwala KS, Maffei M, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science, 1995, 269, 543-6.
2. Ryan AS, Elahi. The effects of acute hyperglycemia and hyperinsulinemia on plasma leptin levels: its relationships with body fat, visceral adiposity, and age in women. J Clin Endocrinol Metab, 1996, 81, 4433-8.
3. Nagasaka S, Ishikawa S, Nakamura T, et al. Association of endogenous insulin secretion and mode of therapy with body fat and serum leptin levels in diabetic subjects. Metabolism, 1998, 47, 1391-6.
4. Carantoni M, Abassi F, Azhar S, Schaaf P, Reaven GM. Can changes in plasma insulin concentration explain the variability in leptin response to weight loss in obese women with normal glucose tolerance? J Clin Endocrinol Metab, 1999, 84, 869-72.
5. Abassi F, Carantoni M, McLaughlin, Reaven GM. Plasma insulin concentration is more tightly linked to plasma leptin concentration than is the body mass index. Metabolism, 2000, 49, 544-7.
6. DeMarinis L, Mancini D, Valle A, et al. Plasma leptin levels after biliopancreatic diversion: Dissociation with body mass index. J Clin Endocrinol Metab, 1999, 84, 2386-9.
7. Ramchandaran A, Snehalatha C, Vijay K, Satyavani K, Latha E, Haffner SM. Plasma leptin in non-diabetic Asian Indians: association with abdominal adiposity. Diabetic Med, 1997, 14, 937-41.
8. Banerji MA, Faridi N, Atluri R, Chaiken RL, Lebovitz HE. Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. J Clin Endocrinol Metab, 1999, 84, 137-44.
9. Cnop M, Landchild MJ, Vidal J, et al. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations. Distinct metabolic effects of two fat compartments. Diabetes, 2002, 51, 1005-15.
10. World Health Organization. Diabetes Mellitus: Report of a WHO Study Group Geneva, World Health Org, 1985 (Tech. Rep. Ser., no. 727).
11. Ma Z, Gingerich RL, Santiago JV, Klein S, Smith CH, Landt M. Radioimmunoassay of leptin in human plasma. Clin Chem, 1996, 42, 942-6.
12. Yoshizumi T, Nakamura T, Yamane M, et al. Abdominal fat: standardized technique for measurement at CT. Radiology, 1999, 211, 283-6.
13. Taniguchi A, Nakai Y, Sakai M, et al. Relationship of regional adiposity to insulin resistance and serum triglycerides level in nonobese Japanese type 2 diabetic patients. Metabolism, 2002, 51, 544-8.
14. Haffner SM, D'Agostino R Jr, Mykkanen L, et al. Insulin sensitivity in subjects with type 2 diabetes: relation to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study. Diabetes Care, 1999, 22, 562-8.
15. Nagasaka S, Tokuyama K, Kusaka I, et al. Endogenous glucose production and glucose effectiveness in type 2 diabetic subjects derived from stable-labeled minimal model approach. Diabetes, 1999, 48, 1054-60.
16. Taniguchi A, Nakai Y, Fukushima M, et al. Pathogenic factors responsible for glucose tolerance in patients with NIDDM. Diabetes, 1992, 41, 1540-6.
17. Taniguchi A, Fukushima M, Sakai M, et al. The role of the body mass index and triglyceride levels in identifying insulin-sensitive and insulin-resistant variants in Japanese non-insulin-dependent diabetic patients. Metabolism, 2000, 49, 1001-5.
18. Taniguchi A, Fukushima M, Sakai M, et al. Remnant-like particle cholesterol, triglycerides, and insulin resistance in nonobese Japanese type 2 diabetic patients. Diabetes Care, 2000, 23, 1766-9.
19. Abate N, Garg A, Peshock RM, Stray-Gundersen J, Adams-Hhuet B, Grundy SM. Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM. Diabetes, 1996, 45, 1684-93.
20. Taniguchi A, Nakai Y, Doi K, et al. Insulin sensitivity, insulin secretion, and glucose effectivenss in obese subjects: a minimal model analysis. Metabolism, 1995, 44, 1397-400.
21. Zachwieja JJ, Hendry LS, Smith RS, Harris RBS. Voluntary wheel running decreases adipose tissue mass and expression ofleptin mRNA in Osborne-Mendel rats. Diabetes, 1997, 46, 1159-66.
22. Harmelen VV, Reynisdottir S, Eriksson A, et al. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes, 1998, 47, 913-7.
23. Taniguchi A, Okuda H, Oseko F, et al. Regional differences in carboxylesterase activity between human subcutaneous and omental adipose tissue. Life Sci, 1985, 36, 1465-71.